Calendar Beam Therapeutics Inc.

Equities

BEAM

US07373V1052

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
23.9 USD -1.69% Intraday chart for Beam Therapeutics Inc. -7.83% -12.20%

Chart calendar Beam Therapeutics Inc.

60c968758e69f616759d828d7f.ebuEGTkvKva7Fm0LfKHjm54siTeQxWn_L6fig3bo_6w.KfXqfVocb5DfVBd9JfKn6u9auWDk8yqcXfKVzTKGrs0e_rJGaG5Gn8NdWQ~b7bb6e10b46f8c3621bf4edef32870d5

Upcoming events on Beam Therapeutics Inc.

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Beam Therapeutics Inc.

2024-03-13 02:35 pm Barclays Global Healthcare Conference
2024-03-11 02:40 pm Leerink Partners Global Biopharma Conference
2024-03-06 12:50 pm TD Cowen Health Care Conference
2024-02-27 06:30 am Q4 2023 Earnings Release
2024-02-08 10:30 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-08 02:15 pm JPMorgan Healthcare Conference
2023-11-15 11:30 am Jefferies London Healthcare Conference
2023-11-08 06:30 am Q3 2023 Earnings Release
2023-10-24 European Society of Gene & Cell Therapy Congress
2023-09-26 10:00 am BMO BioPharma Virtual Spotlight Series
2023-09-07 10:15 am Wells Fargo Healthcare Conference
2023-09-07 08:50 am Citi BioPharma Conference
2023-08-08 06:30 am Q2 2023 Earnings Release
2023-06-06 11:30 am Annual General Meeting
2023-05-30 10:20 am Stifel Tailoring Genes Genetic Medicines Day
2023-05-24 11:05 am Barclays Gene Editing and Gene Therapy Summit
2023-05-19 07:30 pm American Society of Gene Cell Therapy Meeting
2023-05-19 03:00 pm American Society of Gene Cell Therapy Meeting
2023-05-17 11:00 am RBC Global Healthcare Conference - Fireside Chat
2023-05-10 06:30 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,02
0,00
350%
0,02
0,01
84.62%
51,8
12,5
316.19%
60,9
54,2
12.37%
378
93,7
303.31%

63,4

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-385
-383
-0.64%
-324
-332
2.22%
-156
-398
60.67%

-431

EBIT
Million USD
Released
Forecast
Spread
-75,2
-68,9
-9.08%
-133
-128
-3.46%
-392
-387
-1.31%
-338
-336
-0.61%
-176
-409
56.84%

-459

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-78,3
-71,5
-9.47%
-195
-132
-47.44%
-371
-369
-0.42%
-260
-322
19.27%
-131
-356
63.12%

-457

Net income
Million USD
Released
Forecast
Spread
-91,0
-74,3
-22.56%
-196
-134
-45.63%
-371
-367
-0.92%
-289
-337
14.25%
-133
-337
60.65%

-452

EPS
USD
Released
Forecast
Spread
-2,49
-2,29
-8.46%
-4,19
-2,94
-42.3%
-5,77
-5,80
0.59%
-4,13
-4,85
14.77%
-1,72
-4,37
60.66%

-5,44

Announcement Date30/03/2015/03/2128/02/2228/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
51,1
9,64
429.6%
8,43
44,2
-80.9%
16,7
9,44
76.43%
15,8
7,15
120.95%
20,0
12,7
57.35%
24,2
15,6
54.78%
20,1
16,8
19.41%
17,2
23,9
-28.04%
316
33,7
839.01%

14,7


14,7


14,8


14,8


0,00

EBITDA
Million USD
Released
Forecast
Spread
-60,9
-71,6
14.96%
-72,9
-210
65.36%



-87,8
-70,1
-25.29%
-85,0
-95,2
10.69%



-97,3
-71,8
-35.49%
-103
-87,2
-18.26%
138
-97,7
241.43%

-109


-110


-111


-112




EBIT
Million USD
Released
Forecast
Spread
-63,5
-62,4
-1.69%
-76,2
-57,8
-31.83%
-82,0
-74,9
-9.37%
-91,3
-91,8
0.59%
-89,0
-94,7
6.03%
-98,9
-95,3
-3.8%
-102
-106
3.68%
-108
-109
0.55%
133
-108
222.95%

-124


-124


-122


-125


-115

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-64,7
-59,4
-8.97%
-69,2
-25,5
-171.86%
-72,0
-76,3
5.69%
-81,7
-93,8
12.94%
-37,3
-99,4
62.43%
-96,5
-94,1
-2.52%
-82,8
-109
23.84%
-96,1
-106
9.03%
144
-78,3
284.23%

-121


-117


-117


-121


-114

Net income
Million USD
Released
Forecast
Spread
-64,7
-61,4
-5.32%
-69,2
-34,3
-101.81%
-72,0
-73,4
1.95%
-110
-90,8
-20.63%
-38,3
-95,4
59.81%
-96,5
-93,0
-3.67%
-82,8
-103
19.79%
-96,1
-97,1
1.08%
143
-57,5
348.41%

-119


-115


-115


-119


-114

EPS
USD
Released
Forecast
Spread
-0,95
-0,95
-0.31%
-1,01
-0,89
-13.61%
-1,02
-0,97
-4.94%
-1,56
-1,30
-19.76%
-0,54
-1,35
59.93%
-1,33
-1,33
-0.36%
-1,08
-1,39
22.27%
-1,22
-1,25
2.47%
1,73
-0,81
314.15%

-1,44


-1,39


-1,38


-1,40


-1,35

Announcement Date28/02/2209/05/2209/08/2207/11/2228/02/2310/05/2308/08/2308/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BEAM Stock
  4. Calendar Beam Therapeutics Inc.